Health and Fitness Health and Fitness
Tue, July 31, 2012
[ Tue, Jul 31st 2012 ] - Market Wire
Alseres Pharmaceuticals, Inc. Reports License of .. ldwide Rights to Navidea Biopharmaceuticals, Inc.
[ Tue, Jul 31st 2012 ] - Market Wire
Depomed Announces Submission Of Serada NDA
[ Tue, Jul 31st 2012 ] - Market Wire
Orexigen Therapeutics Schedules August 7, 2012 We .. Results for the Second Quarter Ended June 30, 20
[ Tue, Jul 31st 2012 ] - Market Wire
New York Genome Center Purchases Four Ion Protona" Sequencers for its new Innovation Center
[ Tue, Jul 31st 2012 ] - Market Wire
Neurocrine Biosciences Reports Second Quarter 2012 Results
[ Tue, Jul 31st 2012 ] - Market Wire
MAP Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
[ Tue, Jul 31st 2012 ] - Market Wire
Optigenex Inc. Announces Settlement With Secured Note Holders
[ Tue, Jul 31st 2012 ] - Market Wire
Hospira Expands Board of Directors With Election of Dennis M. Fenton
[ Tue, Jul 31st 2012 ] - Market Wire
Synergy Pharmaceuticals to Present Scientific Pos .. nterology Society Meetings in the U.S. and Europe
[ Tue, Jul 31st 2012 ] - Market Wire
Accuray Incorporated to Report Financial Results for Fourth Quarter and Fiscal Year 2012
[ Tue, Jul 31st 2012 ] - Market Wire
Mylan Specialty L.P. Partners with the Pittsburgh .. Sponsor PNC Park's First Allergy Awareness Night
[ Tue, Jul 31st 2012 ] - Market Wire
Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
[ Tue, Jul 31st 2012 ] - Market Wire
Fresh Start Private Announces New Web Presence
[ Tue, Jul 31st 2012 ] - Market Wire
BIOLASE Establishes Long-Term Collaboration With .. y Expert Professor Norbert Gutknecht and the Aach
[ Tue, Jul 31st 2012 ] - Market Wire
Ohr Pharmaceutical Issues Letter to Shareholders
[ Tue, Jul 31st 2012 ] - Market Wire
China Cord Blood Corporation Files its Annual Report on Form 20-F
[ Tue, Jul 31st 2012 ] - Market Wire
Sarepta Therapeutics Announces Second Quarter 201 .. cial Results and Corporate Update Conference Call
[ Tue, Jul 31st 2012 ] - Market Wire
CMC Biologics Acquires XOMA's Bay Area Manufacturing Facility
[ Tue, Jul 31st 2012 ] - Market Wire
Aethlon Medical Reports Undetectable Hepatitis C .. Initiation of Hemopurifier Therapy in Genotype-1
[ Tue, Jul 31st 2012 ] - Market Wire
Zynex Schedules Second Quarter 2012 Earnings Release and Webcast
[ Tue, Jul 31st 2012 ] - Market Wire
La Jolla Pharmaceutical Company Announces FDA Agr .. Clinical Trial of GCS-100 in Chronic Kidney Disea
[ Tue, Jul 31st 2012 ] - Market Wire
Rockwell Medical Completes Patient Enrollment in .. ls for SFP Iron-Delivery in Hemodialysis Patients
[ Tue, Jul 31st 2012 ] - Market Wire
Novadaq to Present at the Canaccord Genuity 32nd Annual Growth Conference
[ Tue, Jul 31st 2012 ] - Market Wire
FDA Accepts NuPathe's Migraine Patch NDA Resubmission for Filing
[ Tue, Jul 31st 2012 ] - Market Wire
Omeros Announces Discovery in MASP-2 Program
Mon, July 30, 2012
[ Mon, Jul 30th 2012 ] - Market Wire
Catherine Sohn Elected To Jazz Pharmaceuticals Board Of Directors
[ Mon, Jul 30th 2012 ] - Market Wire
Acura Pharmaceuticals Announces Second Quarter 2012 Financial Results
[ Mon, Jul 30th 2012 ] - Market Wire
Amerigroup Leadership Honored to Serve on Higher Education Boards
[ Mon, Jul 30th 2012 ] - Market Wire
diaDexus, Inc. to Host Webcast August 7, 2012 on Second Quarter 2012 Financial Results
[ Mon, Jul 30th 2012 ] - Market Wire
Sarepta Therapeutics to Present Company Overview .. acGrow Life Sciences Management Access Conference

Sarepta Therapeutics to Present Company Overview at the Wedbush PacGrow Life Sciences Management Access Conference


Published on 2012-07-30 13:19:37 - Market Wire
  Print publication without navigation


July 30, 2012 16:05 ET

Sarepta Therapeutics to Present Company Overview at the Wedbush PacGrow Life Sciences Management Access Conference

Webcast Accessible via Sarepta Therapeutics Website

CAMBRIDGE, MA--(Marketwire - Jul 30, 2012) - Sarepta Therapeutics (NASDAQ: [ SRPT ]), a developer of innovative RNA-based therapeutics, announced today that it is scheduled to present at the 2012 Wedbush PacGrow Life Sciences Management Access Conference in New York, NY on Tuesday, August 14, 2012 at 2:30 p.m. Eastern Time. Chris Garabedian, Sarepta's President and CEO, will be the presenter.

The presentation will be webcast live under the events section of Sarepta Therapeutics' website at [ www.sareptatherapeutics.com ] and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta Therapeutics

Sarepta Therapeutics -- formerly AVI BioPharma -- is focused on developing first-in-class RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases. The Company's diverse pipeline includes its lead program eteplirsen, for Duchenne muscular dystrophy, as well as potential treatments for some of the world's most lethal infectious diseases. Sarepta aims to build a leading, independent biotech company dedicated to translating its RNA-based science into transformational therapeutics for patients who face significant unmet medical needs. For more information, please visit us at [ www.sareptatherapeutics.com ].


Contributing Sources